ACB - Aurora Cannabis Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

ACB

AURORA CANNABIS INC.

NASDAQ

$4.01

▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$248.39 M

52w High$6.67

52w Low$2.56

Dividend Yield—

Frequency—

P/E-8.19

Volume1.08M

Shares Out.61.94M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Miguel Martin

ABOUT

SECTOR

Healthcare

WENT PUBLIC

July 15, 2014

METHOD OF GOING PUBLIC

Dual Listing

FULL TIME EMPLOYEES

1,028

PRICE TARGET

Target High$8.75

Target Low$1.00

Target Median$8.00

Target Consensus$5.92

UPCOMING EARNINGS

DateNov 4, 2026

DayWednesday

Rev. Est.$52.06M

NOV

WED

SPLIT RECORD

DATE	TYPE	RATIO
2024-02-20	Reverse	1:10
2020-05-11	Reverse	1:12

PRICE

$4.01 ▲ UP 0.00% (+$0.00)

OVERLAYS

About Aurora Cannabis Inc.

https://www.auroramj.com ↗

Aurora Cannabis Inc. produces, distributes, and develops medical and recreational cannabis products, accessories, and related services globally, including research, breeding, manufacturing, and patient support through various brands and facilities.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT AURORA CANNABIS INC. IS KNOWN FOR

Black Jelly

Aurora's proprietary, high-THC (27%) medical cannabis cultivar, recently launched in Poland, exemplifies its shift to science-driven, high-margin products in the growing European medical cannabis market.

COMPETITORS

COMPETITOR

Revenue by Geography

REGION	FY2021	FY2022	FY2025	FY2026
Country of domicile	—	$159.46M	—	—
Europe	—	—	$83.35M	$131.84M ▲
European Union	$29.98M	$61.52M ▲	—	—
AUSTRALIA	—	—	—	$39.03M
NEW ZEALAND	—	—	—	$5.65M
Other Geographical Areas	$4.2M	$359K ▼	—	—